Anti-infectious hydrogel compositions

Details for Australian Patent Application No. 2005220708 (hide)

Owner Hydromer, Inc.

Inventors Gruening, Rainer; Perschbacher, Doug J.; Buongiovanni, David; Qu, Xing Yun

Agent Davies Collison Cave

Pub. Number AU-B-2005220708

PCT Pub. Number WO2005/086641

Priority 10/788,663 27.02.04 US

Filing date 18 February 2005

Wipo publication date 22 September 2005

Acceptance publication date 12 November 2009

International Classifications

A61K 31/785 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/086641 Priority application(s): WO2005/086641

12 November 2009 Application Accepted

  Published as AU-B-2005220708

18 March 2010 Standard Patent Sealed

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005220723-Heteroarylaminopyrazole derivatives useful for the treatment of diabetes

2005220706-Improved efficacy and safety of targeted particulate agents with decoy systems